AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

GLUCOSE MONOHYDRATE

8 registrations across 4 African markets— 3 active

Markets with GLUCOSE MONOHYDRATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
GLUCOSE DO PHARMA 10% SOLUTION POUR PERFUSION EN IV FLACON DE 500ML🇨🇮Côte d'IvoireDO PHARMA S.AactiveFeb 2029
DEXATAS 5% Solution for Infusion
Solution For Infusion
🇰🇪KenyaTasa Pharma LimitedactiveDec 2027
DEXATAS 50 % Concentrate for Solution for Infusion
Concentrate For Solution For Infusion
🇰🇪KenyaTasa Pharma LimitedactiveDec 2027
SABAX GLUCOSE 35%🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdsuspendedSept 2025
GLUCOSE DO PHARMA 5% SOLUTION POUR PERFUSION EN IV FLACON DE 500ML🇨🇮Côte d'IvoireDO PHARMA S.AexpiredFeb 2024
GLUCOSE DO PHARMA 5% SOLUTION POUR PERFUSION EN IV FLACON DE 250ML🇨🇮Côte d'IvoireDO PHARMA S.AexpiredFeb 2024
GLUCOSE_10%_IV 10%W/V INFUSION
INFUSION
🇲🇼MalawiexpiredJun 2018
GLUCOSE_5% 5%W/V IV INFUSION
IV INFUSION
🇲🇼MalawiexpiredJun 2018

GLUCOSE MONOHYDRATE in Africa — Regulatory Overview

GLUCOSE MONOHYDRATE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Kenya, Malawi, South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 3 (38%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.